LEVOX Performance — Lazard US Equity Concentrated Portfolio, Open Shares
Data updated: 2026-05-28
LEVOX returned −4.05% year to date and +18.82% over one year to Mar 2026. Annualised returns are +6.70% over 3 years and +4.03% over 5 years. Against its US Large Value category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $121, against $150 for the category, and to $119 over one year, against $115. Volatility over the past three years was 16.89% a year. In the 12 months to Mar 2026 the fund lost a net $23.6M, and assets reached $31.69M.
LEVOX Growth of $100
What $100 invested in Lazard US Equity Concentrated Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | LEVOX | Category average |
|---|---|---|
| 1 year (Apr 2025 – Mar 2026) | $119 | $115 |
| 3 years (Apr 2023 – Mar 2026) | $121 | $150 |
| 5 years (Apr 2021 – Mar 2026) | $122 | $159 |
| Since data start (Jul 2019 – Mar 2026) | $156 | $203 |
LEVOX Trailing Returns
Total returns to Mar 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −4.05% |
| 1 year | +18.82% |
| 3 years (annualised) | +6.70% |
| 5 years (annualised) | +4.03% |
LEVOX Annual Returns
Calendar-year total returns of Lazard US Equity Concentrated Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Mar) | −4.05% |
| 2025 | +7.49% |
| 2024 | +10.38% |
| 2023 | +16.02% |
| 2022 | −20.08% |
| 2021 | +25.72% |
| 2020 | +8.65% |
| 2019 (Jul–Dec) | +8.18% |
LEVOX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.6% | −4.5% | −4.0% | — | — | — | — | — | — | — | — | — |
| 2025 | +7.8% | −7.3% | −13.2% | −2.0% | +4.3% | +7.5% | +3.9% | −2.0% | +1.8% | +4.7% | +3.0% | +0.8% |
| 2024 | −1.7% | +2.3% | +2.9% | −6.0% | +1.8% | +3.9% | +2.0% | +6.1% | +1.8% | −0.5% | +2.5% | −4.5% |
| 2023 | +8.5% | −3.3% | +3.7% | +0.1% | −1.5% | +6.3% | +0.3% | −3.7% | −5.1% | −4.1% | +9.8% | +5.5% |
| 2022 | −5.9% | −2.9% | +3.0% | −5.3% | −1.6% | −7.8% | +9.4% | −6.0% | −9.5% | +5.8% | +5.4% | −4.7% |
| 2021 | −1.6% | +5.6% | +4.8% | +6.4% | −1.3% | +1.1% | +2.6% | +1.8% | −4.1% | +4.8% | −2.1% | +5.7% |
| 2020 | +1.8% | −8.8% | −14.2% | +10.9% | +5.3% | −0.4% | +3.1% | +5.0% | −1.4% | −1.8% | +9.9% | +2.0% |
| 2019 | — | — | — | — | — | — | +3.4% | −1.0% | +0.9% | −0.5% | +1.9% | +3.2% |
LEVOX Risk
Risk measures from monthly returns over Apr 2023 – Mar 2026.
- 3-year volatility (annualised): 16.89%
- 3-year Sharpe ratio: 0.13 (vs 4.5% risk-free rate)
- Best month: +9.84% (Nov 2023)
- Worst month: −13.20% (Mar 2025)
LEVOX Fund Flows
Monthly money in and out of Lazard US Equity Concentrated Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$23.6M
- 12-month gross sales (incl. reinvestments): $1.4M
- Sales ÷ redemptions: 0.06×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Mar 2026 | $27K | $1.3M | −$1.3M |
| Feb 2026 | $13K | $1.4M | −$1.4M |
| Jan 2026 | $728K | $753K | −$25K |
| Dec 2025 | $43K | $3.3M | −$3.2M |
| Nov 2025 | $37K | $2.4M | −$2.4M |
| Oct 2025 | $68K | $2.2M | −$2.1M |
| Sep 2025 | $108K | $1.0M | −$925K |
| Aug 2025 | $114K | $749K | −$635K |
| Jul 2025 | $53K | $1.0M | −$994K |
| Jun 2025 | $29K | $2.5M | −$2.4M |
| May 2025 | $50K | $6.4M | −$6.3M |
| Apr 2025 | $163K | $2.0M | −$1.8M |
LEVOX Assets Under Management
Net assets of Lazard US Equity Concentrated Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-03-31 | $31.69M |
| 2025-12-31 | $35.74M |
| 2025-09-30 | $40.20M |
| 2025-06-30 | $41.25M |
| 2025-03-31 | $47.38M |
| 2024-12-31 | $61.90M |
| 2024-09-30 | $84.31M |
| 2024-06-30 | $95.04M |
| 2024-03-31 | $142.89M |
| 2023-12-31 | $204.56M |
| 2023-09-30 | $345.49M |
| 2023-06-30 | $596.06M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.